Development of a computerized adverse drug event monitor.
about
The anatomy of decision support during inpatient care provider order entry (CPOE): empirical observations from a decade of CPOE experience at Vanderbilt.Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia.Computerized survelliance of adverse drug reactions in hospital: pilot studyDetecting adverse events using information technologyComparison of computerized surveillance and manual chart review for adverse events.Understanding pharmacist decision making for adverse drug event (ADE) detection.A systematic review to evaluate the accuracy of electronic adverse drug event detectionDevelopment and testing of tools to detect ambulatory surgical adverse events.Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signalsDetection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital settingPrevention of adverse drug events through computerized surveillance.Health innovation for patient safety improvement.Comparing the effectiveness of computerized adverse drug event monitoring systems to enhance clinical decision support for hospitalized patients.Assessing the performance characteristics of signals used by a clinical event monitor to detect adverse drug reactions in the nursing home.Countering imbalanced datasets to improve adverse drug event predictive models in labor and delivery.The epidemiology of medication errors: the methodological difficulties.Validation of an electronic surveillance system for acute lung injury.Advantages and Disadvantages of Health Care Accreditation Mod-els.Adverse drug reactions in therapeutic hypothermia after cardiac arrestEffect of CPOE user interface design on user-initiated access to educational and patient information during clinical care.Using a Clinical Data Repository to Estimate the Frequency and Costs of Adverse Drug Events.
P2860
Q30477663-457A70B0-33EC-4102-8279-6E2578E858BCQ33949363-836330F1-66A2-4C6F-AB6A-1310FD9B7A97Q33969571-7BC6D6D8-9E33-4FB3-8904-7E52E6476EACQ34775765-8FBD313F-353D-48ED-BECE-9D4FE366F849Q35082994-BDB340AB-E528-4020-9636-A6F15F09EDA5Q35461828-06654280-BDE3-482D-8DBB-7C7FA9357CFBQ35619108-555E351D-07B2-4BE3-96F1-C4EFC5CDC11FQ36027192-CC49AFCA-646E-408B-9DDA-5E152F6A5C93Q36053234-5E6D217A-FCB2-4BBD-8180-D6E4B9AB1F74Q36053974-ED26C7A0-420B-4794-97C0-110F0E94B423Q36463193-B21F08AF-E514-4E10-B70B-784F7B6F921FQ36469984-EAD4B314-19B3-442B-AB9E-FE9A1D5C631AQ36617461-5B9893C2-6F51-4492-B4E4-2C2C8A86A9A2Q36782901-BDA44D3A-1D3C-4A0F-AC37-368EFB3F278EQ37129158-294AAB4D-71F1-4DD8-8FA1-A51CA43B4765Q37217833-E298199E-5B3B-4FB4-A4D0-A7FDC4D36388Q37295594-9AA9EB72-5A5E-444D-9D57-05C350737DA8Q37314589-EE274462-C72C-4FDC-8837-C486CDF435DBQ37658836-5E454488-C0B1-489F-AFBF-F39F2F7E7193Q37722789-9B57C565-0B82-4D86-83F8-34587343C124Q42055065-A38492F6-DAEC-4236-A120-D4282EEE8CF1Q55547106-62D8180F-DEE3-4D3F-9E14-495EDDA31867
P2860
Development of a computerized adverse drug event monitor.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Development of a computerized adverse drug event monitor.
@ast
Development of a computerized adverse drug event monitor.
@en
type
label
Development of a computerized adverse drug event monitor.
@ast
Development of a computerized adverse drug event monitor.
@en
prefLabel
Development of a computerized adverse drug event monitor.
@ast
Development of a computerized adverse drug event monitor.
@en
P2093
P2860
P1476
Development of a computerized adverse drug event monitor.
@en
P2093
D C Classen
R L Menlove
R M Gardner
S L Pestotnik
P2860
P577
1991-01-01T00:00:00Z